Joshua Hill, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Modulus
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer (previously Medpace/Amplyx
    Topic:
    DSMB for antifungal trial
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SentiBio
    Topic:
    ID expertise in viral infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Takeda
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Up-to-Date
    Topic:
    chapter author
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    06/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead Australia
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    02/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Allovir
    Topic:
    Clinical Trial
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Deverra
    Topic:
    Clinical Trial
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    GeoVax
    Topic:
    Clinical Trial
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Merck
    Topic:
    Research Study
    Date added:
    05/07/2024
    Date updated:
    05/07/2024

Pages

Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility